Eran Ovadia
CEO

Eran Ovadia has been a high-tech manager since 1992. He directed strategic new product development activities in ServiceSoft and Comverse Network Systems. Since 2004 he has led entrepreneurial activities in the areas of biotechnology that ultimately led him to founding the drug development company Immunity Pharma Ltd, based on technologies from the Weizmann Institute of Science. Eran has an MBA degree (Tel Aviv International School of Management) and life science degree (The Hebrew University of Jerusalem).
   

Ilana Cohen, Ph.D.
VP R&D

Dr. Ilana Cohen brings with her over 20 years of experience in pharmaceuticals and biotechnology. Ilana is an expert in biopharmaceutical processes, drug discovery and development, project management and team leadership. Prior to joining the company, Ilana was head of biochemistry and preclinical development as well as the head of analytical R&D at InSight biopharmaceuticals leading innovative and biosimilar projects. Prior to that Ilana was the head of biology at Peptor Ltd., leading projects in drug discovery of peptides and small molecules in the field of cancer and autoimmunity. Dr. Ilana Cohen received her Ph.D. in Neurobiology from the Weizmann Institute of Science and post-doctoral training from Stanford University.